MacroGenics
MGNX
#9009
Rank
โ‚ฌ0.10 B
Marketcap
1,64ย โ‚ฌ
Share price
-2.06%
Change (1 day)
-24.68%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: โ‚ฌ0.10 Billion

As of March 2026 MacroGenics has a market cap of โ‚ฌ0.10 Billion. This makes MacroGenics the world's 9009th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.10 B19.5%
2025โ‚ฌ86.69 M-55.5%
2024โ‚ฌ0.19 B-63.91%
2023โ‚ฌ0.53 B40.37%
2022โ‚ฌ0.38 B-55.74%
2021โ‚ฌ0.86 B-16.88%
2020โ‚ฌ1.04 B

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of MacroGenics was reported to be:

โ‚ฌ0.10 Billion
by Nasdaq info icon info icon
โ‚ฌ0.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ130.27 B 125,638.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ777.46 B 750,318.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ175.18 B 168,987.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ158.19 B 152,589.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ255.38 B 246,396.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ107.46 B 103,628.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.73 B 614.16%๐Ÿ‡บ๐Ÿ‡ธ USA